PRSS-42 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Human PRSS-42 (UniProt Q7Z5A4) recombinant protein expressed in HEK293. Putative testis-expressed serine protease studied for roles in spermatogenesis and meiotic germ cell survival.
Expression system
HEK293
Cat. #
REC-PRSS42

In stock

SKU
REC-PRSS42
$498.00

Target Overview

PRSS-42 (UniProt Q7Z5A4; gene PRSS42P) is a putative serine protease of 293 amino acids annotated under EC 3.4.21.-. It is also referred to in the literature as Testis Serine Protease 2 (Tessp-2) and classified as a serine protease pseudogene-derived protein in humans, with functional orthologues characterised in mouse spermatogenesis studies. The protein localises to the cytoplasm and has been attributed a role in germ cell survival during the meiotic phase of spermatogenesis. This recombinant is produced in a HEK293 mammalian expression system, which supports post-translational processing relevant to the native human protein context. The full 293-residue sequence forms the basis of the expressed construct, making it suitable as a reference standard for structural and functional studies. Researchers use this recombinant in several experimental contexts: as a positive control antigen in Western blot and immunohistochemistry assays, as a standard for evaluating antibody binding affinity and specificity, and as a substrate or enzyme source in biochemical activity assays characterising serine protease function. It is also applicable to inhibitor screening workflows designed to identify small molecules that modulate EC 3.4.21.- class activity. Investigators studying male reproductive biology and the molecular regulation of meiosis will find this reagent well-suited to functional dissection of the PRSS42 locus and its protein product. Researchers requiring a validated antigen for antibody characterisation can pair this recombinant with Triple Point Biologics' matched antibody (SKU: RP-PRSS42), which has been validated for Western blot against human targets. Triple Point Biologics has produced proteinase and inhibitor antibody reagents since 1994, and the RP-PRSS42 antibody was raised and qualified alongside this recombinant standard.

Background

PRSS-42, encoded by the PRSS42P locus (also designated Tessp-2 in rodent nomenclature), belongs to the serine protease family characterised by the catalytic triad motif and classified under EC 3.4.21.-. Although annotated as a pseudogene-derived locus in humans, the protein has drawn sustained research attention because of its functionally characterised murine orthologue, which is expressed in a tightly tissue-restricted pattern within the testis. The biological role of PRSS-42/Tessp-2 was defined in a landmark study by Yoneda et al. (2013), which examined three testis-specific paralogous serine proteases — Tessp-1, Tessp-2, and Tessp-3 — and demonstrated that each plays a distinct, non-redundant role during murine spermatogenesis. Using gene disruption and rescue experiments, that work established Tessp-2 as a factor required for germ cell survival specifically during meiosis, rather than during earlier mitotic amplification or later post-meiotic differentiation stages. Loss of Tessp-2 activity was associated with increased apoptotic elimination of spermatocytes, positioning the protein as a pro-survival protease operating at a critical developmental checkpoint. Transcriptional regulation of the Prss42/Tessp-2 gene has since emerged as a model for studying testis-specific gene expression mechanisms. Satoh et al. (2019) identified Tesra, a long noncoding RNA with exclusive testicular expression, as a positive transcriptional regulator of Prss42/Tessp-2 during spermatogenesis. Subsequent work by Sato et al. (2024) further refined this regulatory axis, demonstrating that the RNA-binding protein PTBP2 interacts physically with Tesra and that this interaction is required for full transcriptional activation of the Prss42/Tessp-2 locus. Together, these studies define a lncRNA–RBP–protease regulatory module that has broader implications for understanding cell-type-specific gene control in germ cells. From a research utility standpoint, the recombinant PRSS-42 protein is applicable to studies investigating serine protease biochemistry in reproductive tissue contexts, characterisation of the lncRNA-mediated transcriptional programmes that govern protease expression, and the development of reagents — including antibodies and small molecule probes — targeting this class of testis-enriched proteases. Male fertility research and the molecular pathology of spermatogenic failure represent active areas where PRSS-42 is studied as a research target. The protein also serves as a well-defined antigen for benchmarking detection reagents, including the paired Triple Point Biologics antibody RP-PRSS42.

Applications

  • Serine protease activity assay using fluorogenic or chromogenic EC 3.4.21.- substrates (e.g., Boc-Ala-Ala-Pro-Phe-AMC)
  • Inhibitor IC50 determination in microplate format against serine protease substrate panels
  • Western blot positive control antigen for anti-PRSS42 antibody validation (pairs with RP-PRSS42)
  • IHC antigen blocking control to confirm anti-PRSS42 staining specificity in testicular tissue sections
  • ELISA capture/detection standard for quantification of endogenous PRSS42 in biological samples
  • Binding affinity measurement (SPR or BLI) for antibody or small-molecule interaction characterisation
  • Recombinant substrate for in vitro cleavage studies exploring protease–substrate relationships in the testis serine protease family
  • Pull-down or co-immunoprecipitation bait protein for identifying PRSS42 protein–protein interaction partners in germ cell lysates

References

  1. Yoneda R, et al. Three testis-specific paralogous serine proteases play different roles in murine spermatogenesis and are involved in germ cell survival during meiosis. Biol Reprod. 2013. doi:10.1095/biolreprod.112.106328 PMID: 23536369
  2. Satoh Y, et al. A novel testis-specific long noncoding RNA, Tesra, activates the Prss42/Tessp-2 gene during mouse spermatogenesis. Biol Reprod. 2019. doi:10.1093/biolre/ioy230 PMID: 30379984
  3. Sato J, et al. PTBP2 binds to a testis-specific long noncoding RNA, Tesra, and activates transcription of the Prss42/Tessp-2 gene. Gene. 2024. doi:10.1016/j.gene.2023.147907 PMID: 37858745

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted (most); pancreas + serum (digestive proteases)

Frequently Asked Questions

What is the expected molecular weight of recombinant PRSS-42 on SDS-PAGE or Western blot?

The full-length PRSS-42 construct spans all 293 residues, giving a predicted molecular weight of approximately 32–33 kDa. On reducing SDS-PAGE, the recombinant typically migrates at 34–37 kDa due to glycosylation added during HEK293 expression. If you are running a non-reducing gel, expect a similar single band — no disulfide-linked dimers have been observed under standard conditions. Purity is >95% by SDS-PAGE, so the preparation is clean enough to use directly as a size reference without further fractionation.

Is PRSS-42 a catalytically active serine protease or a pseudogene-derived non-functional protein?

This is the central question in the field. In humans, PRSS42P is annotated as a pseudogene-derived locus (UniProt Q7Z5A4), and canonical catalytic triad integrity is debated. Mouse functional orthologues (Tessp-2) have demonstrated protease activity in spermatogenesis. This recombinant is expressed in HEK293 cells from the full 293-residue human sequence and is supplied as an active enzyme preparation under EC 3.4.21.- classification, but researchers should validate activity independently using fluorogenic substrates (see activity assay FAQ below) given the unresolved status of the human protein.

What fluorogenic substrate should I use to assay PRSS-42 serine protease activity in vitro?

For initial activity screening, Boc-Val-Pro-Arg-AMC or Z-Phe-Arg-AMC (both broad trypsin-like serine protease substrates) are reasonable starting points given PRSS-42's classification under EC 3.4.21.-. Run assays in 50 mM Tris-HCl pH 7.5, 150 mM NaCl (matching the storage buffer) to avoid buffer-exchange artifacts. Include 1 mM PMSF or 100 µM AEBSF as serine protease inhibitor controls. Because human PRSS-42 activity remains unconfirmed in the literature, a no-enzyme blank and a confirmed serine protease (e.g., trypsin) positive control should be run in parallel to validate assay sensitivity.

What starting concentration and buffer conditions are recommended for a PRSS-42 activity assay?

Start at 0.5–2 µg recombinant PRSS-42 per 100 µL reaction in 50 mM Tris-HCl pH 7.5, 150 mM NaCl — this directly matches the storage buffer, avoiding any dilution-induced precipitation. Substrate concentrations of 50–200 µM AMC-conjugated peptide cover the typical Km range for trypsin-like serine proteases. Incubate at 37°C and read fluorescence (Ex/Em 380/460 nm) at 5-minute intervals over 60 minutes. If signal is low, titrate enzyme up to 5 µg; PRSS-42's activity level in the human form may be modest relative to classical serine proteases.

Can I use recombinant PRSS-42 as a positive control antigen for Western blot with the matched TPB antibody RP-PRSS42?

Yes — that is one of the primary validated uses of this recombinant. The matched rabbit polyclonal antibody RP-PRSS42 (/anti-prss-42-rabbit-polyclonal-antibody) was raised and validated in the same laboratory using this recombinant as immunogen, so antigen-antibody compatibility is confirmed for Western blot. Load 20–50 ng of recombinant PRSS-42 per lane on a standard 12% SDS-PAGE gel; at 50 ng you should resolve a clean band at ~34–37 kDa with RP-PRSS42 at 1:500–1:2000 dilution. This lane serves as a reliable reference when blotting tissue lysates of uncertain expression level.

How much recombinant PRSS-42 should I load for a Western blot positive control lane?

20–50 ng per lane is the practical working range. At 20 ng, the band is detectable with RP-PRSS42 (1:1000) using HRP-conjugated secondary antibody and standard ECL — suitable when minimizing antigen consumption across multiple experiments. At 50 ng, the band is robust enough to serve as a visual reference even on overexposed films. Avoid loading above 100 ng; signal saturation and cross-lane bleed can obscure adjacent sample lanes. Because purity exceeds 95%, no background bands from host-cell contamination are expected at these concentrations.

Does recombinant PRSS-42 from HEK293 cells carry post-translational modifications relevant to native testis protein?

HEK293 expression supports N-linked glycosylation and other mammalian post-translational modifications, which is why this system was chosen over bacterial expression for a testis-expressed protein like PRSS-42. The slight upward shift on SDS-PAGE (predicted ~32–33 kDa, observed ~34–37 kDa) is consistent with glycosylation. Whether the specific glycan pattern matches native testicular PRSS-42 has not been independently confirmed; if glycan identity is critical to your study, PNGase F digestion of the recombinant followed by mass spectrometry is advisable before drawing structural conclusions.

How should I store and handle recombinant PRSS-42 to maintain activity and avoid degradation?

Store at -20°C in single-use aliquots immediately upon receipt. The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — stabilises the protein through freeze-thaw, but repeated cycling will reduce activity and promote aggregation; plan aliquot sizes around a single experiment's needs. On the bench, keep the protein on ice and use within 4 hours of thawing. Do not dilute into water or low-salt buffers; maintain ionic strength to prevent precipitation. Shelf life at -20°C is 12 months from date of receipt when stored correctly. Avoid storage at -80°C for routine use as repeated retrieval increases freeze-thaw risk.

Validation imagery coming soon

Western blot validation figures for REC-PRSS42 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →